Bank Of New York Mellon Corp Spring Works Therapeutics, Inc. Transaction History

Bank Of New York Mellon Corp

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$21.73 - $28.72 $2.74 Million - $3.62 Million	125,918 New	125,918 $3.28 Million
Q3 2022 Nov 14, 2022	BUY	$24.1 - $39.66 $547,865 - $901,590	22,733 Added 17.8%	150,454 $4.29 Million
Q2 2022 Aug 15, 2022	BUY	$18.36 - $60.07 $205,595 - $672,663	11,198 Added 9.61%	127,721 $3.15 Million
Q1 2022 May 11, 2022	SELL	$48.97 - $65.46 $29,479 - $39,406	-602 Reduced 0.51%	116,523 $6.58 Million
Q4 2021 Feb 11, 2022	BUY	$53.3 - $75.84 $40,987 - $58,320	769 Added 0.66%	117,125 $7.26 Million
Q3 2021 Nov 12, 2021	BUY	$62.66 - $88.26 $461,177 - $649,593	7,360 Added 6.75%	116,356 $7.38 Million
Q2 2021 Aug 11, 2021	BUY	$67.45 - $85.63 $1.28 Million - $1.63 Million	19,006 Added 21.12%	108,996 $8.98 Million
Q1 2021 May 13, 2021	SELL	$65.1 - $93.59 $136,840 - $196,726	-2,102 Reduced 2.28%	89,990 $6.62 Million
Q4 2020 Feb 09, 2021	BUY	$48.36 - $77.92 $801,905 - $1.29 Million	16,582 Added 21.96%	92,092 $6.68 Million
Q3 2020 Nov 12, 2020	BUY	$36.14 - $51.99 $19,154 - $27,554	530 Added 0.71%	75,510 $3.6 Million
Q2 2020 Aug 12, 2020	BUY	$22.98 - $48.57 $820,845 - $1.73 Million	35,720 Added 90.98%	74,980 $3.15 Million
Q1 2020 May 06, 2020	BUY	$20.44 - $41.21 $269,378 - $543,106	13,179 Added 50.53%	39,260 $1.06 Million
Q4 2019 Feb 14, 2020	BUY	$17.74 - $39.52 $462,676 - $1.03 Million	26,081 New	26,081 $1 Million

220

66.8M

64.7K

150K

Ticker SWTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,401,100
Market Cap $1.87B
Description
SpringWorks Therapeutics, Inc. acquires, develops, and commercializes medicines for underserved patient populations suffering from rare diseases and cancer. Its lead product candidate is nirogacestat, an oral small molecule gamma secretase inhibitor that is in Phase III clinical trial for the treatment of desmoid tumors. The company is also deve...

Get notified when there are updates to the investment portfolio of Bank Of New York Mellon Corp, based on Form 13F filings with the SEC.

Stay updated on Bank Of New York Mellon Corp with notifications on news.